181 related articles for article (PubMed ID: 9568638)
21. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
Liu G; Shuman MA; Cohen RL
Int J Cancer; 1995 Feb; 60(4):501-6. PubMed ID: 7829264
[TBL] [Abstract][Full Text] [Related]
22. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
23. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
24. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
[TBL] [Abstract][Full Text] [Related]
25. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
Emenaker NJ; Basson MD
J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
[TBL] [Abstract][Full Text] [Related]
26. The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy.
Dunn SE; Torres JV; Nihei N; Barrett JC
Mol Carcinog; 2000 Jan; 27(1):10-7. PubMed ID: 10642432
[TBL] [Abstract][Full Text] [Related]
27. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
28. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
30. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
Ottino P; Taheri F; Bazan HE
Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
[TBL] [Abstract][Full Text] [Related]
32. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
Silvy M; Giusti C; Martin PM; Berthois Y
Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
[TBL] [Abstract][Full Text] [Related]
34. Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Oh SJ; Jung SP; Han J; Kim S; Kim JS; Nam SJ; Lee JE; Kim JH
Oncol Rep; 2013 Apr; 29(4):1343-8. PubMed ID: 23353996
[TBL] [Abstract][Full Text] [Related]
35. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
Festuccia C; Guerra F; D'Ascenzo S; Giunciuglio D; Albini A; Bologna M
Int J Cancer; 1998 Jan; 75(3):418-31. PubMed ID: 9455804
[TBL] [Abstract][Full Text] [Related]
36. Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells.
Han SY; Lee MS; Kim HR; Baek SH; Ahn DH; Chae HS; Erickson RH; Sleisenger MH; Kim YS
Int J Oncol; 2000 Sep; 17(3):487-94. PubMed ID: 10938388
[TBL] [Abstract][Full Text] [Related]
37. Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 breast adenocarcinoma cells invasion/migration by α-tomatine through activating PKCα/ERK/NF-κB-dependent MMP-2/MMP-9 expressions.
Shi MD; Shih YW; Lee YS; Cheng YF; Tsai LY
Cell Biochem Biophys; 2013 May; 66(1):161-74. PubMed ID: 23114726
[TBL] [Abstract][Full Text] [Related]
38. Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression.
Bajou K; Lewalle JM; Martinez CR; Soria C; Lu H; Noël A; Foidart JM
Int J Cancer; 2002 Aug; 100(5):501-6. PubMed ID: 12124797
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
Quax PH; de Bart AC; Schalken JA; Verheijen JH
Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
[TBL] [Abstract][Full Text] [Related]
40. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]